AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitoss M 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Minitoss Medicines

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimitoss M 2mg/1000mg Tablet SR

Diabex Duo 2mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications, including renal impairment, visual disturbances, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan encompassing dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and always carry a rapid-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of heart disease should inform their physician before starting treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glimitoss M 2mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimitoss M 2mg/1000mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitoss M 2mg/1000mg Sustained-Release tablets with a meal.

Common Side effects of Glimitoss M 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitoss M 2mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glimitoss M 2mg/1000mg Extended-Release tablets should be administered with food.

How Glimitoss M 2mg/1000mg Tablet SR works:

Glimitoss M SR tablets (2mg/1000mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimitoss M 2mg/1000mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitoss M 2mg/1000mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimitoss M 2mg/1000mg SR tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimitoss M 2mg/1000mg SR tablets, potentially requiring dosage modification. Consult your physician for guidance. The use of Glimitoss M 2mg/1000mg SR tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitoss M 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimitoss M 2mg/1000mg Tablet SR :

Should you forget a dose of Glimitoss M 2mg/1000mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitoss M 2mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitoss M 2mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitoss M 2mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimitoss M 2mg/1000mg Tablet SR and seek immediate medical attention.
Glimitoss M 2mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimitoss M 2mg/1000mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimitoss M 2mg/1000mg Tablet SR can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental Vitamin B12 intake is recommended at least annually, according to some researchers.
Glimitoss M 2mg/1000mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Consuming alcohol with Glimitoss M 2mg/1000mg Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitoss M 2mg/1000mg Ta...
56
MRP 65
13% off